Daptomycin versus Glycopeptides for the Treatment of <i>Enterococcus faecium</i> Bacteraemia: A Cohort Study

Daptomycin versus Glycopeptides for the Treatment of <i>Enterococcus faecium</i> Bacteraemia: A Cohort Study

Background: Ampicillin resistant and glycopeptide susceptible <i>Enterococcus faecium</i> bloodstream infection (GSEF-BSI) incidence has risen. However, the treatment of choice remains unknown. Daptomycin use for the treatment of enterococcal infections has increased, despite effectivene...

Full description

Bibliographic Details
Main Authors: Daniel Echeverría-Esnal, Luisa Sorli, Nuria Prim, Clara Martin-Ontiyuelo, Juan Pablo Horcajada, Santiago Grau
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antibiotics
Subjects:
<i>Enterococcus faecium</i>
bloodstream infection
bacteraemia
daptomycin
glycopeptides
vancomycin
Online Access:https://www.mdpi.com/2079-6382/10/6/716

Internet

https://www.mdpi.com/2079-6382/10/6/716

Similar Items